
Mo-Sci SCI Corporation, a provider of advanced high-tech glass development and manufacturing, has acquired the assets of 3M’s Advanced Materials business (previously known as 3M Ceradyne). The acquisition included over 350 pieces of specialized equipment and all related intellectual property. Terms of the transaction were not disclosed.
Mo-Sci’s expertise encompasses developing glasses for healthcare, and the technology, IP and asset acquisition expands Mo-Sci’s capabilities and manufacturing capacity for healthcare customers in the production of specialty and bioactive glasses for bone and wound care applications, as well as hemostatic devices
According to Mo-Sci President Joe Bales, customers were the driving force behind the acquisition. He said, “We aggressively pursued this opportunity because 3M’s Advanced Materials business was a highly respected, major player in our industry. The new equipment will enable Mo-Sci to produce a variety of new products and serve a wider customer base, including previous 3M and Ceradyne customers. The addition of their equipment, technologies and IP is going to mean new glass melting capabilities, increased manufacturing capacity and shorter lead times.”
Mo-Sci expects all of the acquired equipment and technology will be fully operational at its Rolla, Missouri headquarters by 4Q23. New employees in operations are being onboarded as part of the manufacturing expansion.
Source: Mo-Sci Corporation
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.